IPI is recruiting a new commercial director! This senior leadership role is a wonderful opportunity to help translate world-class protein science and technology into real-world impact. Find out more: buff.ly/4OvJUnF #sciencejobs #proteinscience #proteomics #commercialdirector #antibodyreagents 🧪

HMS MEDscienceWorks program graduates joined IPI at Emmanuel College this week to learn lab automation, assays and #Python-powered liquid handling. Training the #nextgen of #bioscientists is a big responsibility—one we’re excited to take on as we roll out new courses this year. More soon!

Applications to the IPI Springer-Lu Postdoctoral Fellowship are due on Jan. 20, 2026 — that’s two weeks away! Apply now: buff.ly/Fp8rh51

Proteins positioned within the #synapticcleft govern #synapse formation, maintenance and #neurotransmission. But the exact architecture of this space is still a mystery. IPI’s new #NRXN and #NLGN antibodies could help reveal the blueprint. Order now: buff.ly/AtBazlt

As AI and machine learning capabilities expand, IPI is building nextgeneration Fab and VHH yeast display libraries to yield molecules with better developability. Our bioinformatics scientist Hoan Nguyen is central to this effort! #bioinformatics #proteinscience #proteomics #AI

Lab coats off, holiday spirit on. 🎄✨ We’re wrapping up the year with the people who make our research possible. Cheers to a strong 2025 — and a bright year ahead!

New from the Mizuno Lab, with help from IPI’s Nirakar Basnet: insights into how #microtubule shoots stabilize and repair #axons — and how epothilone B drives CNS regeneration. Read it in Nature: buff.ly/lO9xwIX

🗓️Mark your calendars 🗓️ Applications for the IPI Springer-Lu Postdoctoral Fellowship are due in ONE MONTH. Find out how to apply: buff.ly/2b45pWI #neurojobs #sciencejobs #postdocjobs #proteinscience #proteinengineering

IPI’s glypican antibodies are used in labs around the world to study neurodegenerative diseases, brain development, cancer biology and more — and our collection with @addgene.bsky.social just expanded 🤯 Order reliable recombinant antibodies targeting GPCs 1-6 on our website: buff.ly/QSwEnbQ

We’re excited to announce our plans for a course on antibody validation and characterization — and we need your help! Fill out this survey to shape the course (it’s quick, we promise!) ➡️ buff.ly/KoyJfU9

IPI has launched a postdoc for scientists working in cell-surface protein research/antibody engineering — and we’ve expanded eligibility to include recent MD/PhD/MD-PhD grads + early-career postdocs! Come work with us! buff.ly/45QGcpW #proteinscience #postdocjobs #neurojobs

IPI collaborator Matthew Dalva (@tulanebrain.bsky.social) has a new paper out on the role of extracellular phosphorylation in regulating receptor interactions at synapses, with particular focus on #EphrinB2-NMDAR interaction. Take a look @science.org 👀

IPI is accepting applications to its FIRST postdoctoral fellowship program. Apply now for a 2+ year opportunity to push the boundaries of antibody science and cell-surface protein research! #neurojobs #phdjobs #proteinscience buff.ly/MPh7dR8

Breakthrough work @uwproteindesign.bsky.social combines computation & yeast display to produce #denovo antibodies w/ “atomic accuracy.” We’re exploring how yeast display—key to IPI’s platform—can work in conjunction with AI. More @nature.com: buff.ly/6CJDfzM

What do autism, Alzheimer’s, schizophrenia, depression and obesity have in common? They’ve been linked to mutations in #neurexin genes—and IPI #monoclonalantibodies could help researchers learn more. Order IPI antibodies, including Neurexin 1/2/3: buff.ly/ZUSDGZU

We brought the Antibodies Roadshow back to #SfN2025 — this time on the USS Midway. Researchers shared new #imagingtools, community #antibodydata, and advances in #synapticbiology and #braincircuitry. Read the recap: buff.ly/60ouG8A

Are you a recent or soon-to-be PhD graduate who wants to work with #yeastdisplay, deep sequencing, #proteinexpression, #biophysicalcharacterization, #antibodyvalidation, #confocalmicroscopy, #AI, #ML or #automation? Apply to be an IPI #postdoc! buff.ly/jvpT6MP

Happy thanksgiving from IPI! We’re feeling especially grateful this week for our team and the many scientists, collaborators and partners who share our passion for advancing protein science. Your curiosity drives progress — and inspires us every day 🍂🧬

Congrats to IPI postdoctoral fellow Nirakar Basnet for co-authoring a recent paper @natcomms.nature.com with former colleagues at the Mizuno Lab. They resolved the #cryoEM structure of #SSNA-1, providing a detailed look at its self-assembly and role in #embryonicdevelopment ➡️

Scientists are drawn to their #research for all sorts of reasons, big and small. “What drives my science,” says IPI scientist Alex Morano, “is profound love of humanity and a desire to make the world better and safer for people.” Learn more about IPI’s story: buff.ly/ifaeFo9 #whatdrivesmyscience

There’s some exciting work happening w/ #neuroscience & #antibodies—PRISM barcoding, #synaptome mapping w/ ExA-SPIM, #wholebraintissueclearing and more. Huge thanks to the speakers who shared this work at a recent IPI meeting down the road (harbor? 🚢) from #SfN2025. Read more: buff.ly/Utn94ct

Come work with us! IPI is seeking a #postdoctoralfellow to join us and apply our #antibodydiscovery platforms to cutting-edge questions in #cellsurface #proteinresearch and #antibodyengineering. It could be you! Learn how to apply today: buff.ly/f2cLV4D

🛑 Are you using glypican antibodies to study brain development, neurodegeneration, cancer biology or cell signaling? 🛑 IPI has recombinant antibodies to GPC1-6 and we want you to know about them! So, what’s amazing about our anti-glypicans?

We had such a great time yesterday diving into cell-cell communication and the latest advances in molecular neuroscience on a rainy San Diego day! #SfN2025

New recombinant monoclonal antibodies from @ipiproteins.bsky.social at Addgene targeting Neurexin and Neuroligin — key mediators of synaptic adhesion and function. Explore the collection and advance your neuroscience research: https://twp.ai/4itA72 #neuroscience #neuroskyence

🚨IPI just released new antibodies into the @addgene.bsky.social catalog targeting Neurexin 1/2/3 & Neuroligin 1. Order now! buff.ly/CpP2b8x #ProteinScience #Neuroscience #Antibodies

IPI #researchassociate Minh Anh Kieu helps build and optimize our high-throughput antibody production pipeline — perfect for a problem-solver like her. Find out more about #antibodyproduction at IPI and stay tuned for what drives our science! buff.ly/V4wps8X #proteinscience #proteomics #bioscience

Applications for the Springer-Lu Postdoctoral Fellowship are due Jan. 20 — but now is the perfect time to put your application together, reach out to an external faculty sponsor and apply! Learn more and apply today 👉 buff.ly/vZ4QNLw

Come discuss antibodies with @ipiproteins.bsky.social at #SfN25! Join us Monday, Nov 17 (11–3) in booth # 3625 for IPI office hours. Let’s chat about new tools for axon guidance & the synaptic cleft — and what antibodies you want to see next.

We’re looking forward to the Society for Neuroscience (@sfn.org) conference in San Diego next week! Our team will be catching talks on everything from neuronal cell types to pathways of neurodevelopment and degeneration — and we’d love to connect while we’re there. Here’s where to find us:

IPI just released new glypican antibodies (GPCs1-6) — but what’s a glypican anyway? Read our explainer to find out! Link in bio. buff.ly/LezYIdl

“What drives my research is the real-world impact that we make,” says Swethika Balasankar, a research associate on IPI’s #AntibodyDiscovery team. Find out more about how IPI is shaping #proteinscience 🔬 buff.ly/Fd2qroB

Looking for a #postdoc in applied protein science and engineering? Check out the IPI Springer-Lu Postdoctoral Fellowship. Applications are open until Jan. 20! buff.ly/ko7q2QE #PostDocJobs #PostdocPosition #PhDChat #ScienceJobs #PostdoctoralFellow #STEMCareers

IPI has new glypican #antibodies available! Our latest synthetic #recombinants target #GPC1, #GPC2, #GPC4, #GPC5 and #GPC6 — which means IPI’s collection now targets the full #glypican family. View our catalog & order today: buff.ly/4zh0UfE

What drives Sophea Sann-Rorth’s work at IPI? Seeing how incremental experiments step us closer to understanding human health and saving people’s lives. At IPI, we provide synthetic antibodies and deep protein expertise, empowering this progress. Join our newsletter to learn more! buff.ly/0M4VsFX

As a postdoc in the Milstein lab, IPI co-founder Tim Springer learned the power of #monoclonalantibodies — a discovery that defined his career. Now, he’s paying it forward with a new #postdoctoralfellowship supporting the next generation of #proteinscience. Learn more & apply today: buff.ly/RVoRcDV

Buried in the history of #monoclonalantibodies is a lesson in the open exchange of knowledge and materials. Read the story in Nature:

In 2021, Chang Yang joined IPI as a senior research associate. By 2025, she had co-authored a book chapter, mentored teammates, and contributed to a massive increase in antigen production. Read her story: buff.ly/Bj2riuS

Have you heard? IPI is accepting applications to its FIRST #postdoctoralfellowship. Apply now for a 2+ year opportunity to push the boundaries of antibody science and cell-surface protein research: buff.ly/tQ6AWzA

It’s the people at IPI and big picture impact that make all the hard work worth it for research associate Karunya Rajaraman. Find out more about protein science at IPI: buff.ly/0tw6hUq

The role of glypicans in the nervous system is still being uncovered. In this preprint, researchers @hopkinsmedicine.bsky.social @oneneurojhu.org show GPC6 plays a role in nuclear pore complex integrity and TDP-43 nuclear function, with potential to impact neurological function ➡️

📢 IPI is excited to announce the launch of the Springer-Lu #PostdoctoralFellowship!📢 We’re recruiting an early-career fellow to apply IPI's platform to cutting-edge investigations in #proteinscience & #molecularbiology. Apply now! buff.ly/lCULeU4 #PostDocJobs #PostdocPosition #PhDChat #ScienceJobs

Hello from the #PRIMESummit @cytiva.bsky.social! What an incredible opportunity to get into the details of #proteinpurification, #labautomation and #antibodydiscovery, right here in Boston! Learn more about the IPI platform: buff.ly/zNIF9vw

This fall, we’re diving behind the scenes to hear what drives protein science research at IPI. For IPI research associate Chris Lowe, it’s the constant excitement of lab automation! Learn more about IPI: buff.ly/4ui9uS8

We’re happy to see @addgene.bsky.social President and Executive Director Chonnettia Jones named one of Endpoints News 2025 Top Women in Biopharma R&D — a wonderful addition to the list and a valued partner in IPI antibody distribution!

“What drives my research is the fact that IPI is a nonprofit and committed to open science,” says IPI research associate Leo Fletcher. Find out more about how we’re providing protein tools and knowledge to the research community! buff.ly/r0Aheai

Chonnettia Jones, Addgene’s President & Executive Director, is one of Endpoints News’ 2025 Top Women in Biopharma R&D! She is driving Addgene’s growth to enable more discovery and innovation, powered by the sharing of scientific resources. 🔗

For Chang Yang, science is personal. The early loss of her grandmother to cancer inspired a career in #biotechnology — and, at IPI, she found the tools and mentorship to grow as a scientist. Read more: buff.ly/Eif7FQB

“What drives my research is my passion for immunology,” says IPI #researchassociate Fabbiha Hossain. Here at IPI, we play a role , but our #proteinreagents go on to impact #biologicaldiscovery in a multitude of ways, including in the field of #immunology. Learn more about IPI: buff.ly/HHMWKf5

Using a synthetic yeast display nanobody library, IPI cofounder Andrew Kruse & @harvardmed.bsky.social colleagues found #nanobodies that modulate AT1R function, distinct from small molecules. A promising step for nanobody drugs & compelling use of #yeastdisplay ➡️ academic.oup.com/mam/article/...